Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.17 - $1.92 $3,267 - $5,362
-2,793 Reduced 38.93%
4,381 $6,000
Q4 2023

Feb 13, 2024

SELL
$0.6 - $1.31 $1,465 - $3,200
-2,443 Reduced 25.4%
7,174 $6,000
Q3 2023

Nov 14, 2023

SELL
$1.05 - $3.37 $46,807 - $150,231
-44,579 Reduced 82.26%
9,617 $10,000
Q2 2023

Aug 21, 2023

BUY
$2.44 - $4.53 $34,413 - $63,891
14,104 Added 35.18%
54,196 $140,000
Q1 2023

May 09, 2023

SELL
$3.72 - $5.4 $2,462 - $3,574
-662 Reduced 1.62%
40,092 $163,000
Q4 2022

Feb 14, 2023

BUY
$3.41 - $12.93 $4,061 - $15,399
1,191 Added 3.01%
40,754 $204,000
Q3 2022

Nov 18, 2022

SELL
$12.59 - $17.67 $5,753 - $8,075
-457 Reduced 1.14%
39,563 $517,000
Q2 2022

Aug 15, 2022

SELL
$10.58 - $17.5 $920 - $1,522
-87 Reduced 0.22%
40,020 $513,000
Q1 2022

May 16, 2022

SELL
$13.81 - $18.6 $41,789 - $56,283
-3,026 Reduced 7.02%
40,107 $612,000
Q4 2021

Feb 15, 2022

BUY
$17.26 - $22.02 $13,083 - $16,691
758 Added 1.79%
43,133 $764,000
Q3 2021

Nov 15, 2021

SELL
$20.15 - $26.19 $21,782 - $28,311
-1,081 Reduced 2.49%
42,375 $891,000
Q2 2021

Aug 16, 2021

BUY
$15.06 - $30.03 $70,044 - $139,669
4,651 Added 11.99%
43,456 $857,000
Q1 2021

May 18, 2021

BUY
$24.99 - $31.93 $68,472 - $87,488
2,740 Added 7.6%
38,805 $1.13 Million
Q4 2020

Feb 16, 2021

BUY
$16.21 - $31.44 $3,744 - $7,262
231 Added 0.64%
36,065 $1.09 Million
Q3 2020

Nov 17, 2020

BUY
$15.59 - $19.97 $6,828 - $8,746
438 Added 1.24%
35,834 $570,000
Q2 2020

Aug 17, 2020

SELL
$11.97 - $23.47 $27,926 - $54,755
-2,333 Reduced 6.18%
35,396 $699,000
Q1 2020

May 13, 2020

BUY
$10.0 - $19.51 $4,350 - $8,486
435 Added 1.17%
37,729 $465,000
Q4 2019

Feb 14, 2020

BUY
$9.97 - $20.28 $265,650 - $540,360
26,645 Added 250.21%
37,294 $690,000
Q3 2019

Nov 15, 2019

BUY
$13.09 - $18.19 $3,861 - $5,366
295 Added 2.85%
10,649 $147,000
Q2 2019

Aug 14, 2019

BUY
$12.56 - $16.6 $130,046 - $171,876
10,354 New
10,354 $152,000

Others Institutions Holding NGM

About NGM BIOPHARMACEUTICALS INC


  • Ticker NGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,365,904
  • Description
  • NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...
More about NGM
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.